Essex Investment Management’s Procept Biorobotics PRCT Stock Holding History

Essex Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,298	Closed	-$2.32M	–	320
2025 Q2	$2.32M	Sell	40,298 -233	-0.6%	-$13.2K	0.42%	97
2025 Q1	$2.36M	Sell	40,531 -11,194	-22%	-$764K	0.49%	83
2024 Q4	$4.16M	Sell	51,725 -29,267	-36%	-$2.5M	0.75%	38
2024 Q3	$6.49M	Buy	80,992 +228	+0.3%	+$16.2K	1.13%	16
2024 Q2	$4.93M	Buy	80,764 +20,648	+34%	+$1.23M	0.92%	29
2024 Q1	$2.97M	Buy	60,116 +336	+0.6%	+$16K	0.59%	60
2023 Q4	$2.51M	Sell	59,780 -254	-0.4%	-$8.65K	0.49%	73
2023 Q3	$1.97M	Buy	+60,034	New	+$2.05M	0.32%	104

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Essex Investment Management's PRCT Position: Q3 2025 in Review

Essex Investment Management sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 40,298 shares — an estimated $2.32M sold.

Essex Investment Management first reported a position in PRCT in Q3 2023 and held it in 8 quarters. The position peaked at $6.49M in Q3 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

Essex Investment Management reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
Essex Investment Management sold 40,298 Procept Biorobotics shares in Q3 2025, an estimated $2.32M.
Essex Investment Management first reported a position in Procept Biorobotics in Q3 2023 and held it in 8 quarters.
Essex Investment Management's Procept Biorobotics position peaked at $6.49M in Q3 2024.
242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Essex Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.